# Comparing Human Albumin Versus Hydroxyethylstarch in Renal Transplant Recipients

> **NCT03306914** · NA · COMPLETED · sponsor: **Cairo University** · enrollment: 120 (actual)

## Conditions studied

- Anesthesia Morbidity

## Interventions

- **OTHER:** Albumin resuscitation
- **OTHER:** Hydroxyethylstarch resuscitation
- **DRUG:** Albumin 5%
- **DRUG:** Hydroxyethylstarch 6%

## Key facts

- **NCT ID:** NCT03306914
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-15
- **Primary completion:** 2019-02-01
- **Final completion:** 2019-02-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2020-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03306914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03306914, "Comparing Human Albumin Versus Hydroxyethylstarch in Renal Transplant Recipients". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03306914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*